• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铜在肝细胞癌中的作用:一把具有治疗潜力的双刃剑。

Copper in hepatocellular carcinoma: A double-edged sword with therapeutic potentials.

机构信息

Cancer Research Center, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, China; International Co-operation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute/Hospital, Second Military Medical University, Shanghai, 200438, China; National Center for Liver Cancer, Second Military Medical University, Shanghai, 201805, China.

International Co-operation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute/Hospital, Second Military Medical University, Shanghai, 200438, China; National Center for Liver Cancer, Second Military Medical University, Shanghai, 201805, China.

出版信息

Cancer Lett. 2023 Sep 1;571:216348. doi: 10.1016/j.canlet.2023.216348. Epub 2023 Aug 9.

DOI:10.1016/j.canlet.2023.216348
PMID:37567461
Abstract

Copper is a necessary cofactor vital for maintaining biological functions, as well as participating in the development of cancer. A plethora of studies have demonstrated that copper is a double-edged sword, presenting both benefits and detriments to tumors. The liver is a metabolically active organ, and an imbalance of copper homeostasis can result in deleterious consequences to the liver. Hepatocellular carcinoma (HCC), the most common primary liver cancer, is a highly aggressive malignancy with limited viable therapeutic options. As research advances, the focus has shifted towards the relationships between copper and HCC. Innovatively, cuproplasia and cuproptosis have been proposed to depict copper-related cellular growth and death, providing new insights for HCC treatment. By summarizing the constantly elucidated molecular connections, this review discusses the mechanisms of copper in the pathogenesis, progression, and potential therapeutics of HCC. Additionally, we aim to tentatively provide a theoretical foundation and gospel for HCC patients.

摘要

铜是维持生物功能所必需的辅助因子,也是癌症发展的参与者。大量研究表明,铜是一把双刃剑,对肿瘤既有好处也有危害。肝脏是一个代谢活跃的器官,铜动态平衡的失衡会对肝脏造成有害的后果。肝细胞癌(HCC)是最常见的原发性肝癌,是一种侵袭性很强的恶性肿瘤,治疗选择有限。随着研究的进展,人们的注意力转向了铜与 HCC 之间的关系。创新性地提出了铜质形成和铜死亡来描述与铜相关的细胞生长和死亡,为 HCC 的治疗提供了新的见解。通过总结不断阐明的分子联系,本综述讨论了铜在 HCC 的发病机制、进展和潜在治疗中的作用机制。此外,我们旨在为 HCC 患者提供一个理论基础和福音。

相似文献

1
Copper in hepatocellular carcinoma: A double-edged sword with therapeutic potentials.铜在肝细胞癌中的作用:一把具有治疗潜力的双刃剑。
Cancer Lett. 2023 Sep 1;571:216348. doi: 10.1016/j.canlet.2023.216348. Epub 2023 Aug 9.
2
DLAT as a Cuproptosis Promoter and a Molecular Target of Elesclomol in Hepatocellular Carcinoma.DLAT 作为肝癌中铜死亡的促进因子和埃斯库来素的分子靶点。
Curr Med Sci. 2023 Jun;43(3):526-538. doi: 10.1007/s11596-023-2755-0. Epub 2023 Jun 8.
3
Cuproptosis as the new kryptonite of cancer: a copper-dependent novel cell death mechanism with promising implications for the treatment of hepatocellular carcinoma.铜死亡:肿瘤的新克星——一种依赖铜的新型细胞死亡机制,为肝癌治疗带来新希望。
J Cancer Res Clin Oncol. 2023 Dec;149(19):17663-17670. doi: 10.1007/s00432-023-05456-w. Epub 2023 Oct 16.
4
Deep learning enables the discovery of a novel cuproptosis-inducing molecule for the inhibition of hepatocellular carcinoma.深度学习发现一种新型诱导铜死亡分子,可抑制肝癌。
Acta Pharmacol Sin. 2024 Feb;45(2):391-404. doi: 10.1038/s41401-023-01167-7. Epub 2023 Oct 6.
5
Comprehensive analysis of cuproptosis-related lncRNAs in immune infiltration and prognosis in hepatocellular carcinoma.全面分析肝细胞癌中铜死亡相关 lncRNAs 与免疫浸润和预后的关系。
BMC Bioinformatics. 2023 Jan 3;24(1):4. doi: 10.1186/s12859-022-05091-1.
6
Targeting the TCA cycle through cuproptosis confers synthetic lethality on ARID1A-deficient hepatocellular carcinoma.通过铜死亡靶向 TCA 循环赋予 ARID1A 缺陷型肝细胞癌合成致死性。
Cell Rep Med. 2023 Nov 21;4(11):101264. doi: 10.1016/j.xcrm.2023.101264. Epub 2023 Nov 7.
7
Copper in colorectal cancer: From copper-related mechanisms to clinical cancer therapies.结直肠癌中的铜:从与铜相关的机制到临床癌症治疗。
Clin Transl Med. 2024 Jun;14(6):e1724. doi: 10.1002/ctm2.1724.
8
A cuproptosis random forest cox score model-based evaluation of prognosis, mutation characterization, immune infiltration, and drug sensitivity in hepatocellular carcinoma.基于铜死亡随机森林 Cox 评分模型评估肝细胞癌的预后、突变特征、免疫浸润和药物敏感性。
Front Immunol. 2023 Mar 30;14:1146411. doi: 10.3389/fimmu.2023.1146411. eCollection 2023.
9
Research progress in cuproptosis in liver cancer.肝癌中铜死亡的研究进展。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023;48(9):1368-1376. doi: 10.11817/j.issn.1672-7347.2023.230083.
10
The Role of Ferroptosis and Cuproptosis in Curcumin against Hepatocellular Carcinoma.姜黄素抗肝细胞癌作用中的铁死亡和铜死亡机制。
Molecules. 2023 Feb 8;28(4):1623. doi: 10.3390/molecules28041623.

引用本文的文献

1
Copper metabolism and cuproptosis: broad perspectives in the treatment of hepatocellular carcinoma.铜代谢与铜死亡:肝细胞癌治疗的广阔前景
Front Oncol. 2025 Jul 30;15:1555858. doi: 10.3389/fonc.2025.1555858. eCollection 2025.
2
Targeting cuproptosis opens a new chapter of nanomedicine: a scientometric and graphical analysis.靶向铜死亡开启了纳米医学的新篇章:科学计量与图形分析
Naunyn Schmiedebergs Arch Pharmacol. 2025 Aug 12. doi: 10.1007/s00210-025-04497-x.
3
Targeting cuproptosis in liver cancer: Molecular mechanisms and therapeutic implications.
靶向肝癌中的铜死亡:分子机制与治疗意义
Apoptosis. 2025 Aug 7. doi: 10.1007/s10495-025-02150-9.
4
Differences in Tissue Copper and Zinc Content Between Normal Livers and Those with Cirrhosis with or Without Hepatocellular Carcinoma.正常肝脏与伴有或不伴有肝细胞癌的肝硬化肝脏组织中铜和锌含量的差异
Int J Mol Sci. 2025 Jul 8;26(14):6571. doi: 10.3390/ijms26146571.
5
Nanobubble-mediated sonodynamic therapy enhances cuproptosis in the treatment of hepatocellular carcinoma.纳米气泡介导的声动力疗法增强铜死亡在肝细胞癌治疗中的作用。
Nanoscale Adv. 2025 Jun 12. doi: 10.1039/d5na00280j.
6
Biodegradable Mg-Cu alloy inhibits HBV replication and hepatocellular carcinoma progression.可生物降解的镁铜合金抑制乙肝病毒复制和肝细胞癌进展。
Biometals. 2025 Jun 14. doi: 10.1007/s10534-025-00703-8.
7
Copper metabolism in hepatocellular carcinoma: from molecular mechanisms to therapeutic opportunities.肝细胞癌中的铜代谢:从分子机制到治疗机遇
Front Mol Biosci. 2025 May 13;12:1578693. doi: 10.3389/fmolb.2025.1578693. eCollection 2025.
8
MiR-133a-5p Facilitates Cuproptosis in Hepatocellular Carcinoma Through Targeting of ATP7B.MiR-133a-5p通过靶向ATP7B促进肝细胞癌中的铜死亡。
J Inflamm Res. 2025 May 22;18:6607-6622. doi: 10.2147/JIR.S515647. eCollection 2025.
9
The molecular mechanism and therapeutic landscape of copper and cuproptosis in cancer.癌症中铜及铜死亡的分子机制与治疗前景
Signal Transduct Target Ther. 2025 May 9;10(1):149. doi: 10.1038/s41392-025-02192-0.
10
Responsive ROS-Augmented Prodrug Hybridization Nanoassemblies for Multidimensionally Synergitic Treatment of Hepatocellular Carcinoma in Cascade Assaults.用于在级联攻击中对肝细胞癌进行多维协同治疗的响应性活性氧增强前药杂交纳米组装体
Adv Sci (Weinh). 2025 May 5:e2501420. doi: 10.1002/advs.202501420.